GB0707348D0 - Medicaments and methods for inhibition of scarring - Google Patents

Medicaments and methods for inhibition of scarring

Info

Publication number
GB0707348D0
GB0707348D0 GBGB0707348.9A GB0707348A GB0707348D0 GB 0707348 D0 GB0707348 D0 GB 0707348D0 GB 0707348 A GB0707348 A GB 0707348A GB 0707348 D0 GB0707348 D0 GB 0707348D0
Authority
GB
United Kingdom
Prior art keywords
scarring
medicaments
inhibition
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0707348.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Priority to GBGB0707348.9A priority Critical patent/GB0707348D0/en
Publication of GB0707348D0 publication Critical patent/GB0707348D0/en
Priority to JP2010503583A priority patent/JP2010524910A/ja
Priority to EP08737006A priority patent/EP2148726A1/en
Priority to CA002684368A priority patent/CA2684368A1/en
Priority to PCT/GB2008/001345 priority patent/WO2008125869A1/en
Priority to AU2008237751A priority patent/AU2008237751A1/en
Priority to US12/596,332 priority patent/US20100261659A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB0707348.9A 2007-04-17 2007-04-17 Medicaments and methods for inhibition of scarring Ceased GB0707348D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0707348.9A GB0707348D0 (en) 2007-04-17 2007-04-17 Medicaments and methods for inhibition of scarring
JP2010503583A JP2010524910A (ja) 2007-04-17 2008-04-17 瘢痕の抑制に使用できる分泌性Ｆｒｉｚｚｌｅｄ関連タンパク質
EP08737006A EP2148726A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring
CA002684368A CA2684368A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring
PCT/GB2008/001345 WO2008125869A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring
AU2008237751A AU2008237751A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring
US12/596,332 US20100261659A1 (en) 2007-04-17 2008-04-17 Secreted frizzled related protein 3 for use in the inhibition of scarring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0707348.9A GB0707348D0 (en) 2007-04-17 2007-04-17 Medicaments and methods for inhibition of scarring

Publications (1)

Publication Number Publication Date
GB0707348D0 true GB0707348D0 (en) 2007-05-23

Family

ID=38116837

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0707348.9A Ceased GB0707348D0 (en) 2007-04-17 2007-04-17 Medicaments and methods for inhibition of scarring

Country Status (7)

Country Link
US (1) US20100261659A1 (enExample)
EP (1) EP2148726A1 (enExample)
JP (1) JP2010524910A (enExample)
AU (1) AU2008237751A1 (enExample)
CA (1) CA2684368A1 (enExample)
GB (1) GB0707348D0 (enExample)
WO (1) WO2008125869A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8725477B2 (en) 2008-04-10 2014-05-13 Schlumberger Technology Corporation Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics
WO2009126888A2 (en) 2008-04-10 2009-10-15 Services Petroliers Schlumberger Method for characterizing a geological formation traversed by a borehole
US8311788B2 (en) 2009-07-01 2012-11-13 Schlumberger Technology Corporation Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry
KR102022116B1 (ko) 2011-06-24 2019-09-18 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049291B2 (en) * 1996-10-11 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation and method of using tissue growth-inducing Frzb protein
EP1012262A4 (en) * 1997-08-12 2002-11-06 Human Genome Sciences Inc HFLP PROTEIN HFLP
EP1639097B1 (en) * 2003-06-25 2013-08-07 Ottawa Health Research Institute Methods and compositions for modulating stem cell growth and differentiation
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
US7638128B2 (en) * 2005-08-19 2009-12-29 The Brigham And Women's Hospital, Inc. Method of enhancing cardiac tissue repair by administering a SFRP polypeptide

Also Published As

Publication number Publication date
AU2008237751A1 (en) 2008-10-23
JP2010524910A (ja) 2010-07-22
WO2008125869A1 (en) 2008-10-23
CA2684368A1 (en) 2008-10-23
EP2148726A1 (en) 2010-02-03
US20100261659A1 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
PT2397142T (pt) Utilizações de inibidores da dpp iv
ZA201404552B (en) Benzoxepin pi3k inhibitor compound and use thereof
ZA201001051B (en) Benzylbenzene derivatives and methods of use
IL199727A0 (en) Inhibitors of mek
IL209763A0 (en) Triazolopyridine jak inhibitor compounds and methods
IL209764A0 (en) Triazolopyridine jak inhibitor compounds and methods
ZA200806150B (en) Therapeutic uses of inhibitors of RTP801
EP2200977A4 (en) F1F0-ATPASE INHIBITOR AND ASSOCIATED METHODS
GB0724231D0 (en) Methods for inhibiting scarring
IL200576A0 (en) Inhibitors of rtp801 and their uses
IL201367A0 (en) 2 - morpholin - 4 - yl - pyrimidines as pi3k inhibitors
SI2379096T1 (sl) Zaviralci TFPI in postopki uporabe
EP2242501A4 (en) THERAPEUTIC INHIBITORS OF PAI-I FUNCTION AND METHODS OF USE
IL209512A0 (en) Inhibitor of analgesic tolerance
GB0622084D0 (en) Inhibitors of HSP90
GB0702930D0 (en) Medicaments and methods for inhibition of scarring
GB0719248D0 (en) Compounds and methods for pharmaceutical use
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
GB0707348D0 (en) Medicaments and methods for inhibition of scarring
GB0810063D0 (en) Medicaments and methods for inhibition of scarring
ZA200900708B (en) Use of WNT5A for inhibiting scarring
GB0714934D0 (en) Medicaments and methods for inhibition of scarring
GB0625966D0 (en) Medicaments and methods for promoting wound contraction
IL202766A0 (en) Pharmaceutical combination of opioid and prostaglandin compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)